Radiotherapy With GX Regimen as Adjuvant Therapy for High-risk Patients Following Pancreatic Cancer Surgery
Clinical trial NCT07632118 · RECRUITING
Trial details
- NCT number
- NCT07632118
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2029-05-01
- Enrollment
- 288
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.